• New horizons in the pathogenesis, pathophysiology and treatment of familial hypercholesterolaemiaViigimaa, Margus; Heinsar, Silver; Lovic, Dragan; Katsimardou, Alexandra; Piperidou, Alexia; Duishvili, DavitCurrent pharmaceutical design2018 / p. 3599-3604 https://doi.org/10.2174/1381612824666181009105305 https://www.scopus.com/sourceid/20682 https://www.scopus.com/record/display.uri?eid=2-s2.0-85060024681&origin=inward&txGid=23d487431ca81928057cd9221a82c69d https://jcr.clarivate.com/jcr-jp/journal-profile?journal=CURR%20PHARM%20DESIGN&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000454705800002
• Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS familial hypercholesterolaemia studies collaboration (FHSC)Vallejo-Vaz, Antonio J.; De Marco, Martina; Viigimaa, MargusAtherosclerosis2018 / p. 234-255 https://doi.org/10.1016/j.atherosclerosis.2018.08.051 https://www.scopus.com/sourceid/22483 https://www.scopus.com/record/display.uri?eid=2-s2.0-85053666909&origin=inward&txGid=76ca416561a8c72f5ee8970ce6403007 https://jcr.clarivate.com/jcr-jp/journal-profile?journal=ATHEROSCLEROSIS&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000445908000037